Health
What GLP-1 Drugs Actually Do Inside Your Body
GLP-1 receptor agonists did not start as weight loss drugs. Here is the biology behind Ozempic, Mounjaro and the hormone they mimic.
Jan 25, 2024
Loading
Search
Results
60 stories for“signalling”
FilterAll 60Health 12Business 10Fashion 8Diving 7Technology 7Crypto 4Travel 4Nutrition 3Latest Trends 2Design 1Lifestyle 1Sports 1
Health
Diabetic Nerve Damage Can Mean Burning Pain or Feeling Nothing at All. It Is the Same Condition
One patient cannot bear a bedsheet touching their feet. Another cannot feel a nail through their shoe. Both have diabetic neuropathy, and the second is in more danger than the first.
Jul 28, 2026
Health
Retatrutide: The Triple Agonist Still Proving Itself
Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026
Health
PRIMA’s Retinal Implant Wins Approval to Restore Vision
A tiny implant paired with camera glasses can return useful central vision to some people with advanced macular degeneration, and Europe has cleared its sale.
Jul 23, 2026
Health
The Same Word Is on Your Serum, Your Collagen Powder and the Vial Someone Is Selling on Telegram
Peptide is a chemical category, not a claim. The two versions most people actually buy are the ones with the least regulation and, oddly, the best safety record. Here is what the trials support and what physics gets in the way of.
Aug 20, 2026
Health
GLP-1 Drugs Are Becoming More Than Weight Loss Medicine
Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025
Health
The Immune System Appears to Remember Obesity for Years After the Weight Has Gone
Work in EMBO Reports finds obesity leaves a chemical mark on CD4 T cells that outlasts weight loss. The authors suggest the immune system may need years of sustained maintenance to reset, and say plainly that no long term human study confirms it.
Sep 1, 2026
Health
Ashwagandha Has Good Trial Data for Stress and a Growing File of Liver Injury Reports
The most popular Ayurvedic herb in the world looks reassuring in clinical trials and much less so in hepatology case series. A systematic review has identified thirty-seven cases of ashwagandha-associated liver injury.
Sep 4, 2026
Health
GLP-1 Side Effects and Who Should Not Take Them
Nausea is the least of it. Here is an honest look at GLP-1 side effects, the thyroid warning, pancreatitis and who is advised to avoid them.
Jul 10, 2024
Health
Watching From Abroad: When the War Is at Home and You Are Not
For much of the Gulf's working population, the conflict is somewhere their family lives and they do not. The particular difficulty of that position is helplessness, and there are things that genuinely help with it.
Aug 13, 2026
Health
Continuous Glucose Monitors Without Diabetes: Useful Data or Noise?
Over-the-counter glucose monitors reached healthy consumers in 2024, but research suggests their readings may not mean what wearers assume.
Jul 22, 2025
Health
Retatrutide's Third Receptor Is the Hormone That Raises Blood Sugar. Adding It On Purpose Is the Whole Idea
Semaglutide hits one receptor and tirzepatide hits two. The third one retatrutide adds is glucagon, which does the opposite of what a diabetes drug is supposed to do. It is also where the liver results and the safety questions both come from.
Aug 20, 2026
